If you need to inquire about Bayer drug/medical device/health food/cosmetic, please contact us through the following telephone:


Hotline: 400-810-0360 (available by mobile or telephone)


We will try our best to provide you the information about Bayer products, but we can't propose any specific diagnosis and treatment suggestions for patients' conditions. If you have any discomfort after medication, please go to see your doctor and receive timely medical treatment.


If you need to report your discomfort or quality issue after using Bayer product, please contact your doctor or the local drug regulatory authority respectively, or please contact us through the above telephone number.


To ask other question about Bayer China, please send e-mail to webmaster.china@bayer.com .


close

Bayer 150 years

To celebrate the anniversary, numerous events are planned to take place around the world.

About Bayer

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials.

Innovation

Innovation plays an important role in overcoming global challenges and is a key driver of future growth at Bayer.

Products

With our distinctive knowledge of people, animals, plants and materials, we intend to focus in future on the areas of health care, nutrition and high-tech materials.

Sustainability

Read more about our economic, ecological and social challenges and opportunities.

Career

Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.

Media

This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.

Corporate Social Responsibility

As a highly socially responsible company, the Bayer Group for its operations around the world to fulfill its responsibility as a corporate citizen.
News
About Bayer
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. >> more
Search
Product
Themes
Publication
Bayer Global
Special Interest
Media
Follow Us
Share Price/Index